Theriva Biologics, Inc. research brief
CIK 894158
Generated Nov. 17, 2026, 9:37 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: ROCKVILLE Maryland. Reported legal jurisdiction: NEVADA. These do not establish investor residence or where funds were deployed.
- Oct. 24, 2025 · D · 0001104659-25-101914 · Source evidence
Reported offering amount: 13109494 USD. Reported amount sold: 13109494 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Theriva Biologics, Inc. research brief,” CIK 894158, retrieved Nov. 17, 2026, 9:37 p.m.. Cite the specific accessions used. No amounts have been summed.